Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Towards the development of small molecule therapy for chikungunya
- In: Short Communications A1 on Monday, 22 May 2017, 13:30-15:00
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: CHAI, Christina (National University of Singapore, Pharmacy, Singapore, Singapore)
- Co-author(s): Kuan Chieh Ching: Department of Pharmacy, National University of Singapore, Singapore, Singapore
Thi Ngoc Quy Tran: Department of Pharmacy, National University of Singapore, Singapore, Singapore
Yiu Wing Kam: Singapore Immunology Network, A*STAR, Singapore, Singapore
Lisa Ng: Singapore Immunology Network, A*STAR, Singapore, Singapore
Christina Chai: Department of Pharmacy, National University of Singapore, Singapore, Singapore - Abstract:
Backgrounds
Chikungunya is a mosquito borne viral disease that is transmitted by the Aedes aegypti and Aedes albopictusmosquito. Although the disease is rarely fatal except in the vulnerable population, it is frequently debilitating and complications from the disease (e.g. arthralgia) can become chronic. Recent years have seen more (severe)
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023